J. Anim Sci.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dunshea, F. R.
Right arrow Articles by Hennessy, D. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dunshea, F. R.
Right arrow Articles by Hennessy, D. P.

Journal of Animal Science, Vol 79, Issue 10 2524-2535, Copyright © 2001 by American Society of Animal Science


CLINICAL TRIAL

Vaccination of boars with a GnRH vaccine (Improvac) eliminates boar taint and increases growth performance

F. R. Dunshea, C. Colantoni, K. Howard, I. McCauley, P. Jackson, K. A. Long, S. Lopaticki, E. A. Nugent, J. A. Simons, J. Walker and D. P. Hennessy
Agriculture Victoria, Victorian Institute of Animal Science, Werribee, Australia. Frank.Dunshea@nre.vic.gov.au

Peri- and postpubertal boars accumulate substances (e.g., androstenone and skatole) in their fatty tissue that are responsible for boar taint in pork. The objective of this study was to assess the efficacy of a GnRH vaccine, Improvac, in eliminating boar taint. Three hundred male (200 intact boars, 100 barrows) crossbred (Large White x Landrace) pigs were used in a 2 x 3 factorially arranged experiment. The respective factors were sex group (barrows, boars treated with placebo, or boars treated with Improvac) and slaughter age (23 or 26 wk). Vaccines were administered 8 and 4 wk before slaughter. All Improvac-treated pigs exhibited anti-GnRH titers. Testes and bulbo-urethral gland weights in treated pigs were reduced by approximately 50% (P < 0.001) and serum testosterone levels were below 2 ng/mL in the majority of treated boars (94 and 92% across both age groups at 2 and 4 wk, respectively). Boar taint, as assessed by the concentration of androstenone and skatole in s.c. fat, was suppressed to low or undetectable levels in 100% of Improvac-treated boars. No Improvac-treated pigs had significant concentrations of either androstenone (> 1.0 microg/g) or skatole (> 0.20 microg/g). In contrast, 49.5% of placebo-treated controls had significant androstenone and 10.8% had significant skatole levels, resulting in 10% of the control boars with high concentrations of both compounds. The mean concentrations of taint compounds in the Improvac-treated pigs were not significantly different from those in barrows. Improvac-treated boars grew more rapidly (P = 0.051 and < 0.001 for pigs slaughtered at 23 and 26 wk of age, respectively) than control boars over the 4 wk after the secondary vaccination, possibly because of reduced sexual and aggressive activities. Compared with barrows, Improvac-treated boars were leaner and had superior feed conversion efficiency. The vaccine was well tolerated by the pigs, and no observable site reactions could be detected at the time of slaughter. Vaccination of boars with Improvac allows production of heavy boars with improved meat quality through prevention and control of boar taint.


This article has been cited by other articles:


Home page
J ANIM SCIHome page
C. Rikard-Bell, M. A. Curtis, R. J. van Barneveld, B. P. Mullan, A. C. Edwards, N. J. Gannon, D. J. Henman, P. E. Hughes, and F. R. Dunshea
Ractopamine hydrochloride improves growth performance and carcass composition in immunocastrated boars, intact boars, and gilts
J Anim Sci, November 1, 2009; 87(11): 3536 - 3543.
[Abstract] [Full Text] [PDF]


Home page
Adv. Physiol. Educ.Home page
R. A. Hill, D. J. Flint, and J. M. Pell
Antibodies as molecular mimics of biomolecules: roles in understanding physiological functions and mechanisms
Advan Physiol Educ, December 1, 2008; 32(4): 261 - 273.
[Abstract] [Full Text] [PDF]


Home page
J ANIM SCIHome page
G. Chen, E. Bourneuf, S. Marklund, G. Zamaratskaia, A. Madej, and K. Lundstrom
Gene expression of 3{beta}-hydroxysteroid dehydrogenase and 17{beta}-hydroxysteroid dehydrogenase in relation to androstenone, testosterone, and estrone sulphate in gonadally intact male and castrated pigs
J Anim Sci, October 1, 2007; 85(10): 2457 - 2463.
[Abstract] [Full Text] [PDF]


Home page
Clin. Microbiol. Rev.Home page
E. N. T. Meeusen, J. Walker, A. Peters, P.-P. Pastoret, and G. Jungersen
Current Status of Veterinary Vaccines
Clin. Microbiol. Rev., July 1, 2007; 20(3): 489 - 510.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
R. K. Naz, S. K. Gupta, J. C. Gupta, H. K. Vyas, and a. G.P. Talwar
Recent advances in contraceptive vaccine development: a mini-review
Hum. Reprod., December 1, 2005; 20(12): 3271 - 3283.
[Abstract] [Full Text] [PDF]


Home page
J ANIM SCIHome page
W. T. Oliver, I. McCauley, R. J. Harrell, D. Suster, D. J. Kerton, and F. R. Dunshea
A gonadotropin-releasing factor vaccine (Improvac) and porcine somatotropin have synergistic and additive effects on growth performance in group-housed boars and gilts
J Anim Sci, August 1, 2003; 81(8): 1959 - 1966.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the American Society of Animal Science.